U.S. Markets close in 4 mins

CTI BioPharma lays off half of workforce to save cash for lead drug trial

Casey Coombs
CTI BioPharma lays off half of workforce to save cash for lead drug trial

It’s CTI's latest attempt to salvage its pipeline of cancer drug candidates and reinvent the Seattle-based biotech after its co-founder and longtime CEO Dr. James Bianco stepped down in late 2016.